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Enzyme engineeringa b s t r a c t
Enzyme stability is an important parameter in biocatalytic applications, and there is a strong need
for efﬁcient methods to generate robust enzymes. We investigated whether stabilizing disulﬁde
bonds can be computationally designed based on a model structure. In our approach, unlike in pre-
vious disulﬁde engineering studies, short bonds spanning only a few residues were included. We
used cyclohexanone monooxygenase (CHMO), a Baeyer–Villiger monooxygenase (BVMO) from Aci-
netobacter sp. NCIMB9871 as the target enzyme. This enzyme has been the prototype BVMO for many
biocatalytic studies even though it is notoriously labile. After creating a small library of mutant
enzymes with introduced cysteine pairs and subsequent screening for improved thermostability,
three stabilizing disulﬁde bonds were identiﬁed. The introduced disulﬁde bonds are all within
12 Å of each other, suggesting this particular region is critical for unfolding. This study shows that
stabilizing disulﬁde bonds do not have to spanmany residues, as the most stabilizing disulﬁde bond,
L323C–A325C, spans only one residue while it stabilizes the enzyme, as shown by a 6 C increase in
its apparent melting temperature.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction disulﬁde bonds out of the 18 that were experimentally tested [9].Enzyme stability is an important parameter in biocatalysis, as
an increase in stability will improve the economics of enzyme
use in industrial applications [1]. Unfortunately most enzymes
are relatively unstable, not evolved to operate at high tempera-
tures or in the presence of organic solvents. Improvements in ther-
mostability are often laborious and usually require the creation
and screening of large enzyme mutant libraries [2]. In most pro-
teins, stabilizing mutations are found in certain critical regions,
suggesting structural regions that allow early unfolding steps of
an enzyme, while mutations elsewhere in the protein have a much
smaller effect on thermostability [3–5]. Therefore, there is a need
for methods to locate such critical regions [6], to allow enzyme
engineering efforts to focus and so to reduce the amount of labor
required to stabilize an enzyme [7,8].
Recently, we published an improved computational method for
disulﬁde bond design to boost enzyme stability. For limonene
epoxide hydrolase, this resulted in identiﬁcation of 9 stabilizingThe stabilizing disulﬁde bonds were clustered at a critical region
for stability, where also stabilizing point mutations had most effect
[9]. This study showed that by introducing computer-designed
disulﬁde bonds, it is possible to locate the critical region for stabil-
ization using relatively few variants. However, this was done for a
protein for which an X-ray structure was available and it is not
obvious whether such a strategy would work for a protein for
which only a homology model is available. Homology models are
structurally far less accurate than (high resolution) X-ray struc-
tures [10], which could hinder the computational design of stabi-
lizing disulﬁde bonds and thus a higher fraction of non-stabilized
disulﬁde bonds can be expected.
Introduced disulﬁde bonds that contribute to protein stability
typically involve disulﬁde bonds that bridge a large number of res-
idues. The use of disulﬁde bonds spanning only a few residues is a
surprisingly unexplored method to stabilize proteins. Disulﬁde
bonds in natural proteins in majority encompass <30 residues,
with most bonds spanning 11 residues [11]. However, in protein
stability engineering, short disulﬁde bonds are avoided, because it
is assumed that the obtained stabilization by a disulﬁde bond is
dominated by the number of residues that the disulﬁde bond spans
across [12]. This proposed correlation between the obtained
stabilization and the number of spanned residues is however
poorly supported by experimental data. Therefore it appeared
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disulﬁde bonds, which might have been overlooked earlier [13].
In this study, we test whether computational design of disulﬁde
bonds can be used to ﬁnd a region critical for unfolding and to sta-
bilize a coenzyme-dependent and cofactor-containing enzyme,
cyclohexanone monooxygenase from Acinetobacter sp. NCIMB9871
(CHMO), of which no crystal structure is available. While our pre-
vious successful disulﬁde design was based on an X-ray structure
of the target enzyme, this time we applied our in-house developed
computational design protocol on a homology model. An addi-
tional modiﬁcation was the inclusion in the in silico design of short
disulﬁde bonds spanning <15 residues.
The target enzyme, CHMO, can be considered as the prototype
enzyme for Baeyer–Villiger monooxygenases (BVMOs), an enzyme
class that is attracting an ever-increasing interest for being applied
in biocatalytic processes [14–20]. CHMO has been studied for its
biocatalytic potential in numerous studies which has revealed that
it (1) accepts a wide range of aliphatic substrates, (2) is able to per-
form chemo- and regioselective oxidations, and (3) yields absolute
enantioselectivity for many of the tested conversions [19,21]. In
the last decade, it has been the subject of several directed evolution
and site-directed mutagenesis studies, aiming at altering the sub-
strate speciﬁcity or improving the stability [22–25]. Recently this
enzyme was used by Codexis as a starting point in a directed evo-
lution approach to improve the enantioselective production of (S)-
omeprazole, a blockbuster pharmaceutical [26]. So far, CHMO has
deﬁed all crystallization attempts which may partly be due to its
notoriously poor thermostability [27–29]. Yet, to guide enzyme
engineering attempts of CHMO, crystal structures of the homolo-
gous phenylacetone monooxygenase (PAMO) are available
[30,31], and more recently the structure of the more closely related
CHMO from Rhodococcus sp. was elucidated [32,33].
Previously we attempted to access CHMO-like activity in a ther-
mostable enzyme by using PAMO from the thermophile Thermobi-
ﬁda fusca as a scaffold to introduce activities of related BVMOs [34].
PAMO has an apparent melting temperature (Tm) more than 20 C
higher than CHMO, but only has a limited substrate range [19,35].
We were able to expand the substrate speciﬁcity in a PAMO–
CHMO chimera, but activity with the preferred substrate of CHMO,
cyclohexanone, was not detected.Fig. 1. Model structure of CHMO showing the introduced cysteines as spheres. Non-
beneﬁcial mutations are shown in gray, beneﬁcial mutations shown in red. Residues
323–325 are mutated to cysteines in the best mutant, residues 255–293 and 325–
483 were mutated in the other two described mutants. Of the truncation mutant,
the last C-terminal residue is shown in blue. FAD is shown in yellow; NADP+ is
shown in cyan. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)Here we report on the introduction of disulﬁde bonds in CHMO,
designed using a homology model based on the X-ray structure of a
sequence-related CHMO (58% sequence identity). A total of 27
disulﬁde bond mutants were designed in silico and experimentally
tested for their thermostability. Three stabilized mutants were
identiﬁed, which were all located in the same region. This suggests
that this particular region is important for the stabilization of
CHMO. The most stabilized disulﬁde bond variant was
L323C–A325C, with an apparent Tm increase of 6 C and a 12-fold
increased half-life, while its disulﬁde bonds spans only one
residue. This illustrates the importance of taking extremely short
disulﬁde bonds into consideration when designing more stable
proteins.
2. Results
Disulﬁde bonds were designed in a model structure of Acineto-
bacter CHMO (see experimental section). To prevent the loss of cat-
alytic activity, no disulﬁde bonds were allowed between residues
that are within 8 Å from the FAD and NADP+ cofactors bound in
the homology model. Also, the loop between residues 487–504,
which in the Rhodococcus CHMO adopts a different conformation
in the open and closed form of the enzyme [32], was excluded from
mutagenesis. While previously disulﬁde bonds that spanned <15
residues were not allowed [9], here no such restrictions were
implemented. The selected disulﬁde bonds are distributed over
the whole protein, to probe for the regions that are important for
thermostability (Fig. 1). Of the 27 selected disulﬁde bonds, 8
spanned <15 amino acids (Table S1). Additionally, because in the
homology model the C-terminal residues 534–545 could not be
modeled (absent in the crystal structure), this C-terminus was re-
moved in a separate mutant, as the removal of such disordered C-
termini can also increase stability [11].
All mutants were grown in 50 mL TB medium and twenty disul-
ﬁde bond mutants were expressed and puriﬁed in sufﬁcient yield
to determine the apparent melting point in the ThermoFAD exper-
iment. In this experiment the enzyme is heated in a RT-PCR ma-
chine, and by following the increase in FAD ﬂuorescence when it
is released from the protein, the apparent melting point can be
determined. Of the twenty puriﬁed mutants, three displayed a
higher apparent melting temperature than the wild-type CHMO,
while for other disulﬁde bond mutants the apparent melting tem-
perature was similar to the wild-type CHMO or even signiﬁcantly
reduced (Table S1 and Fig. S1). The truncation mutant, missing
10 residues at the C-terminus, was expressed but turned out to
be slightly less stable than the wild-type enzyme (Table 1). The
best mutant, L323C–A325C, showed a 6 C increase in apparent
melting temperature, while two other mutants, A255C–A293C
and A325C–L483C, showed an increase of 2.5 C (Table 1). For these
three mutants the melting curves showed only one maximum,
indicating there are no subpopulations in which the disulﬁde bond
is not formed, or formed improperly (Fig. S2).
In addition to the ThermoFAD measurements, enzyme activity
was monitored at a single temperature to determine the half-life,Table 1
Apparent melting temperatures of all studied CHMO variants.






a The melting point for the reduced form, obtained by incubating the enzyme o/n
with 1.0 mM DTT.
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30 C was followed by measuring BVMO activity with cyclohexa-
none as substrate. This revealed that only the L323C–A325C
mutant displayed a signiﬁcantly increased half-life. The time at
which 50% catalytic activity was left was increased >10 fold to
45 min for this mutant, compared to 4 min for the wild-type en-
zyme (Fig. 2). The other two enzymes show inactivation behavior
similar to the wild-type enzyme (Fig. S8).
To create an even more stable CHMO mutant, beneﬁcial double
mutations were combined. Because the A325C mutation is present
in two of the stabilized variants, only two double disulﬁde bond
mutants could be created. Combining A325C–L483C or L323C–
A325C with A255C–A293C resulted in two separate melting points
in de ThermoFAD experiment (Fig. S3). One subpopulation exhib-
ited a slightly increased apparent melting temperature compared
to the single A255C–A293C mutant for both mutants containing
two disulﬁde bonds. Unfortunately a large fraction of the enzyme
was less stable. Expression levels of the double mutants were also
signiﬁcantly reduced, probably due to misfolding events as result
of the four introduced cysteines.
The L323C–A325C mutant was further investigated as it was the
only mutant showing increased stability in both the ThermoFAD
experiment and the inactivation assay. In the design process, a min-
imum distance from the active site was set to prevent mutations
close to the active site from inﬂuencing the catalytic efﬁciency or
enantioselectivity of the enzyme. To check whether the mutant
was an effective enzyme, steady state kinetic parameterswere deter-
mined (Table 2). While the activity of the mutant was found to be
slightly lower than that of the wild-type enzyme, afﬁnities for both
cyclohexanone and bicyclo[3.2.0]hept-2-en-6-one are increased. It
is worth noting that the activities of the wild-type CHMO and the
mutant on the nonphysiological substrate bicyclo[3.2.0]hept-2-en-6-Fig. 2. Enhanced stability of CHMO by an introduced disulﬁde bond. Enzyme was
incubated at 30 C in the presence of 0.5 mM cyclohexanone and activity was
measured at different time points. The relative initial rates after addition of 100 lM
NADPH are plotted with the activity at t = 0 set to 100%. The L323C–A325C mutant
(open triangles), wild-type (squares) and the reduced L323C–A325C mutant (grey
triangles) are shown here, see Fig. S8 for an extended graph also including data for
the other two single disulﬁde bond mutants.
Table 2
Steady-state kinetic parameters of the studied enzyme variants. Standard errors for kcat v
Enzyme Cyclohexanone Bicyclo[3.2.0]he
kcat (s1) KM (lM) kcat (s1)
WT-CHMO 14.2 3.6 13.4
L323C–A325C 6.1 3.0 4.9one are almost as high as with cyclohexanone, the natural substrate.
For both bicyclo[3.2.0]hept-2-en-6-one and thioanisole the prod-
ucts are formed with complete enantioselectivity for the wild-type
and mutant enzymes. These results show that introduction of the
two cysteines yields a catalytically competent enzyme. From the
apparent half-life and the kcat, the TTN (total turnover number)
was calculated [36]. The TTN for the mutant enzyme (24  103) is
5-fold higher than the TTN for the wild-type enzyme (4.5  103).
The lowered activity of the mutant could be recovered after
incubation with a reducing agent (DTT); after incubation the ob-
served rate increased with 54% (9.4 s1 vs. 6.1 s1). This indicates
that the reduced activity is caused by the formation of a disulﬁde
bond as opposed to the effect of the introduction of two separate
cysteine thiols. The addition of DTT has some inhibitory effect on
the enzyme activity (Fig. S4), but this is insigniﬁcant at the residual
concentration (20 lM) in this experiment.
Because the release of NADP+ is the rate-limiting step in the cat-
alytic cycle of CHMO, a change in the binding or release of NADP+
directly affects the steady state behavior of the enzyme [37]. The
microenvironment of FAD changes upon binding of NADP+, result-
ing in a reduced absorbance, with a maximum decrease at 387 nm.
By observing this change in the spectrum of FAD, the afﬁnity for
NADP+ could be determined. The KD for NADP+ was signiﬁcantly
decreased to 15 lM for the L323C–A325C mutant compared to a
KD of 28 lM for the wild-type enzyme (Table S2 and Fig. S6). Upon
reduction of the enzyme, the KD for NADP+ is increased to 46 lM,
signiﬁcantly above the value for the wild-type enzyme. This agrees
with the effects on the observed rates, suggesting that the forma-
tion of the disulﬁde bond affects the kcat via a change in NADP+
afﬁnity.
The reduction of the L323C–A325C disulﬁde bond was further
investigated by observing the spectroscopic properties of FAD.
During incubation with DTT the spectrum changes and the second-
ary absorbance maximum of the L323C–A325C enzyme at 369 nm
moves to the wild-type value of 380 nm (Fig. S5). In the Thermo-
FAD assay, we observe that incubation with DTT reduces the stabil-
ity of the L323C–A325 mutant by 7.5 C, making the reduced
enzyme more unstable than the wild-type CHMO (Table 1 and
Fig. S2). This experiment also shows that the reduction of the
L323C–A325C mutant is complete, as there is no residual subpop-
ulation with a higher apparent melting temperature. Finally, also in
the time-dependent inactivation experiment the stability of the re-
duced L323C–A325C mutant is dramatically reduced (Fig. 2).3. Discussion
Stabilizing disulﬁde bonds were designed and selected in silico,
based on the model structure of CHMO. Of the 27 mutants contain-
ing two additional cysteines that were created, 20 mutants could
be expressed and puriﬁed. Of this set of mutants, three had a sig-
niﬁcantly higher apparent melting temperature compared to the
wild-type enzyme. The three stabilizing disulﬁde bonds are located
in the same region (Fig. 1), which indicates that this region is
important for thermostability. Thus, it appears to be possible to lo-
cate a critical region for protein thermostability by testing a series
of disulﬁde bonds that are spread over the protein. While thealues are <5%, for KM values <25%. Exact errors are reported in Table S3.
pt-2-en-6-one NADPH
KM (lM) KM (lM) Uncoupling rate (s1)
1.3 16 0.2
0.7 13 0.2
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cannot be investigated whether additional stabilizing disulﬁde
bonds would have been obtained if a high-resolution X-ray struc-
ture had been available. On the other hand the success of this
method makes it a viable approach to design structurally guided
mutants for an enzyme for which no structure is available.
While three of the mutants show a higher apparent melting
point in the ThermoFAD method, only the L323C–A325C mutant
also showed a signiﬁcantly extended lifetime in the time-depen-
dent inactivation experiment. Higher apparent melting tempera-
tures often correlate with an increased half-life at a single
temperature, but this does not always need to be the case, as dur-
ing high temperature melting a different mechanism can occur
than during low temperature inactivation [38–40]. Regardless of
the cause of these differences, the mutant with the longest half-
life, L323C–A325C, could be easily identiﬁed by the ThermoFAD as-
say, conﬁrming its potential as a powerful and simple initial
screening method [41].
The L323C–A325C mutant was investigated in more detail. The
disulﬁde bond lowers the catalytic activity to some extent, but ta-
ken together with the increased stability its TTN was signiﬁcantly
increased (5-fold). This is an important parameter, as it can be used
directly to calculate the economic feasibility of a biocatalytic pro-
cess. Furthermore, enantioselectivities with bicyclo[3.2.0]hept-2-
en-6-one and thioanisole were preserved, and afﬁnities for the
tested (co)substrates were similar. This shows that by preserving
the residues close to the active site and both cofactors, the actual
substrate binding site is not altered. Only the activity of the en-
zyme is slightly reduced.
This activity-reducing effect could be cured by reduction of the
disulﬁde bond, indicating the formation of the bond is the cause for
this change in behavior. The disulﬁde bond is close to residues
324–328, which shift on average 1.7 Å between the open and
closed conformations in CHMO [32]. Furthermore, two conserved
residues important for catalysis, K326 and R327, are located
directly next to the introduced disulﬁde bond (Fig. 3). K326 binds
the phosphate of NADPH and is therefore important for the prefer-
ence towards NADPH over NADH [42,43]. R327 moves 2.7 Å
between the two crystallized CHMO conformations, forming a
hydrogen bond with NADP+ [32]. The bound NADP+ has been
shown to have a role in stabilizing the peroxyﬂavin intermediate
[44] and detailed kinetic analysis of CHMO has revealed that theFig. 3. Modeled structure of the 323–325 disulﬁde bond, K326 and R327. The
interaction of K326 with the phosphate moiety of the NADP+ coenzyme is marked
by the dashed line. The FAD prosthetic group is shown in yellow; the NADP+
coenzyme is shown in cyan. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)release of NADP+ is limiting the rate of catalysis [37]. This indicates
that effects on the binding or release of the coenzyme will directly
translate into effects on the steady-state kinetic behavior. The
introduction of the disulﬁde bond was indeed found to inﬂuence
the binding constant of the nicotinamide cofactor which is in line
with a lowered kcat. Possibly by altering the exact conformation
of the neighboring residues K326 and R327, the disulﬁde bond
had a modest but signiﬁcant kinetic effect even though the cyste-
ines are more than 8 Å away from both cofactors (Fig. 3).
The observation in this study that the most stabilizing engi-
neered disulﬁde bond only spans one residue seems odd in light
of the classical explanation of protein stabilization by disulﬁde
bonds. The common explanation [45] is that the disulﬁde bond pri-
marily stabilizes a protein by lowering the entropy of the unfolded
state. With this explanation it can be derived that a protein should
be stabilized by a disulﬁde bond according to [13,46]:
DS  1:5R ln ðNÞ ð1Þ
In which N is the number of residues spanned by the disulﬁde
bond and R is the gas constant. While this equation was devised
for reversible folding, it is normally assumed that reversible
unfolding precedes irreversible protein inactivation. Thus the
trends predicted by the above equation, a stronger stabilization
at higher N, should also hold for irreversible processes.
However, it has been argued that this explanation should be
abandoned and that Eq. (1) has no predictive value [13,47]. Experi-
mental results as reviewed by [13] reveal no correlation between
the number of residues that disulﬁde bonds encompass and their
stabilizing effect. This lack of correlation is also supported by our
data (Table S1 and Fig. S1), in which a disulﬁde bond that stretches
over 157 residues was less stabilizing than a disulﬁde bridge that
extended across only 1 residue. Other existing arguments against
the validity of Eq. (1) are that its derivation assumes a random coil
in the unfolded state [13], which has been shown to be an oversim-
pliﬁcation, and that enthalpic contributions of disulﬁde bonds to
stability are ﬁve times larger than entropic contributions [47]. Nat-
ure prefers disulﬁde bonds to stretch over relative few residues,
most commonly approximately 11 residues [11,13,48] while Eq.
(1) predicts it should be far more favorable for protein stability to
maximize the number of residues in the disulﬁde loop [46]. An alter-
native explanation for the stabilizing effects of disulﬁde bonds is
that mainly local interactions introduced by the disulﬁde bond sta-
bilize the protein [13]. Thus, since the classical explanation for how
disulﬁde bonds stabilize proteinsmay verywell bewrong,we see no
reason to avoid disulﬁde bonds that stretch over only a few residues.
The results obtained here with a disulﬁde bond that only spans one
residue demonstrate that such disulﬁde bonds encompassing only a
few residues can indeed be of use for stabilizing a protein.
4. Materials and methods
4.1. Materials
DpnI was acquired from New England Biolabs, NADP+ and
NADPH from Oriental Yeast Co., Ni-Sepharose from GE-healthcare
and all other chemicals were from Sigma–Aldrich. Oligonucleo-
tides were synthesized by Euroﬁns MWG Operon and Sigma–Al-
drich. Sequencing to conﬁrm plasmid sequences was done at
GATC-biotech.
4.2. Homology modeling
A homology model was constructed using YASARA [10,49,50].
The homology model was based on the 2.3 Å resolution X-ray
structure of a Rhodococcus sp. CHMO in its closed form, with FAD
and NADPH bound (PDB: 3GWD) [32]. Of the 543 residues from
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58% sequence identity and 75% sequence similarity. After inspec-
tion of an initial model, 33 water molecules of 3GWD were deleted
that appeared to be incompatible with the structure of the
modeled Acinetobacter CHMO. The remaining 116 water molecules,
often making H-bonds between backbones and conserved
side-chains, were preserved. The resulting model was scored under
YASARA and qualiﬁed as ‘‘good’’ with a Z-score of 0.44.
4.3. Design of disulﬁde bond mutants
Disulﬁde bonds were designed by the Disulﬁde Discovery
protocol as described earlier with identical geometric and ener-
getic criteria [9]. The procedure uses MD simulations to sample
the backbone structural ﬂexibility. The protocol for these MD sim-
ulations was described earlier [51]. These MD simulations of the
modeled structure consisted of 5 trajectories that were started
with different initial velocities [52] to obtain independent trajecto-
ries. After using 30 ps to gradually increase the temperature of the
simulation from 5 to 298 K, snapshots of the simulation were
recorded at 750 ps, 1500 ps, 2250 ps, and 3000 ps. These snapshots
were used to search for positions where a disulﬁde bond could be
introduced that falls within the range of geometries observed for
natural disulﬁde bonds [11]. Subsequently, an in silico screening
is used to eliminate disulﬁde bonds that are unlikely to stabilize
the structure because they introduce clearly destabilizing features.
On the resulting structures with disulﬁde bonds a second round of
MD simulations is carried out [9]. This is done to eliminate variants
that increase local ﬂexibility, which is expected to decrease stabil-
ity [53]. In the ﬁrst round 57 disulﬁde bounds were designed of
which 30 were eliminated using MD simulations [53]. All disulﬁde
bonds that were generated by the design procedure and passed
these earlier described in silico screening steps [9] were character-
ized experimentally.
4.4. Site-directed mutagenesis
After 27 mutants were selected to be tested in vitro, the Agilent
primer design tool (www.agilent.com) was used to design the
primers to create these mutants using QuikChange site-directed
mutagenesis. Some modiﬁcations were made on the output of this
tool, as mutations close to other mutations gave overlapping prim-
ers. In those cases, both primers were combined into one long pri-
mer without further adaptations. Oligonucleotide sequences are
available upon request. 2 or 4 primers were used in each PCR reac-
tion, using the PfuUltra II Master Mix (Agilent) as recommended by
the supplier. Primers were ordered as 100 lM stock solutions and
combined (4 or 2 primers) to a ﬁnal concentration of 10 lM. The
pCRE2-CHMO construct was used as a template which results in
expression of CHMO N-terminally fused to a His-tagged phosphite
dehydrogenase that facilitates cofactor regeneration and Ni-afﬁn-
ity puriﬁcation [54]. PCR reactions, digestions with DpnI and trans-
formations to E. coli TOP10 (Invitrogen) were performed in 96-well
plates. Because single mutants are sometimes created using this
PCR-based method, 4 clones per reaction were sent for sequencing
ensuring at least one mutant containing both mutations. Mutants
containing combinations of beneﬁcial disulﬁde bonds were created
in the same manner, using adapted primers where needed to pre-
vent reversions to wild-type residues.
4.5. Growth and puriﬁcation
For each mutant 0.5 mL LB-Amp in a deep-well microtiter plate
was inoculated from a glycerol stock and grown overnight at 37 C.
50 mL TB-Ampwas inoculated with this culture and grown at 24 C
for 2 h. 0.02% (w/v) L-Arabinose was added to induce enzyme pro-duction for 22 h at 24 C. The culture was pelleted and resus-
pended in 5 mL of 50 mM Tris–HCl, pH 7.5 supplemented with
10 lM FAD. Cells were lysed by sonication and cell debris was re-
moved by centrifugation. The resulting cell-free extract was ap-
plied on 200 lL of Ni-Sepharose and incubated for 1 h at 4 C.
The column material was separated from the cell-free extract,
washed with 3 column volumes of 50 mM Tris–HCl, pH 7.5 and
subsequently with 3 column volumes of 50 mM Tris–HCl, pH 7.5
with 5.0 mM imidazole. The enzyme was eluted using 50 mM
Tris–HCl pH 7.5 containing 500 mM imidazole. For smaller puriﬁ-
cations, the enzyme was concentrated and diluted to reduce the
imidazole concentration to 0.5 mM using an Amicon Ultra Cen-
trifugal Filter. Larger scale puriﬁcations were done with selected
enzymes, in those cases a Bio-Rad 10DG desalting column was
used to remove imidazole. Absorbance at 440 nm was used to
determine the concentration of the puriﬁed enzyme, using
13.8 mM1 cm1 as the extinction coefﬁcient [37].
4.6. Activity measurements and kinetics
Activities were determined using 100 lM NADPH, 0.05 lM en-
zyme and 0.5 mM cyclohexanone in 50 mM Tris–HCl pH 8.5 at
20 C. The absorbance decrease at 340 nm was measured to deter-
mine the initial rate. Concentrations of substrates were changed to
allow the determination of the different steady-state kinetic
parameters. The pH of the Tris–HCl buffer was varied between
7.0 and 9.4 to determine the pH optimum. Because of the high
afﬁnity for the substrates, several KM values were measured using
depletion curves, calculating the rate and concentration at every
point in a reaction going to completion. For the chemically reduced
enzymes, the reported kcat is the rate measured at a saturating con-
centration (0.5 mM) of cyclohexanone.
4.7. Stability assays
Inactivation of the enzyme was measured by incubating a solu-
tion containing 0.05 lM of enzyme, 100 lM NADP+, 0.5 mM cyclo-
hexanone in 50 mM Tris–HCl pH 8.5 at 30 C. Samples were taken
at different time points and activity was measured at 30 C after
addition of NADPH (100 lM).
4.8. Reduction of the enzyme
Reduction of the disulﬁde bonds was done with 10 mM DTT
(dithiothreitol) at room temperature, and spectra were collected
every 3 min to follow the reduction. For further experiments, the
enzyme was reduced o/n on ice using 1.0 mM DTT.
4.9. ThermoFAD
The ThermoFAD method [41] was used to determine the appar-
ent melting points of the different enzyme variants. Using an RT-
PCR machine (CFX96-Touch, Bio-Rad) the ﬂuorescence of the FAD
cofactor was monitored using a 450–490 excitation ﬁlter and a
515–530 nm emission ﬁlter, typically used for SYBR Green based
RT-PCR. The temperature was increased with 0.5 C per step, start-
ing at 25 C and ending at 90 C, using a 10 s holding time at each
step. The maximum of the ﬁrst derivative of the observed ﬂavin
ﬂuorescence was taken as the apparent melting temperature.
4.10. Conversions
Reactions with bicyclo[3.2.0]hept-2-en-6-one and thioanisole
were set up to determine the enantioselectivity of the mutant en-
zymes. For this, 1.0 mL of 4.0 lM enzyme, 8.0 lM additional PTDH,
10 mM substrate (thioanisole or bicyclo[3.2.0] hept-2-en-6-one),
H.L. van Beek et al. / FEBS Open Bio 4 (2014) 168–174 17325 mM phosphite and 100 lM NADPH in 50 mM Tris–HCl pH 8.5
was incubated for 16 h at 30 C. Samples were extracted with ethyl
acetate containing 0.01% (v/v) mesitylene, dried over MgSO4 and
analyzed by GC (Chiraldex GT-A column), using separation proto-
cols as described before [35].
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